Breast Cancer

Novel, Existing Biomarkers Advance Targeted Breast Cancer Care

January 21st 2022, 5:45pm

Article

Given the heterogeneous nature of breast cancer, biomarkers evaluated throughout treatment help provide a clearer picture of the treatment paradigm.

Mixed Findings on Breast Cancer Incidence Highlight Potential Care Gaps

January 18th 2022, 11:30pm

Article

A recent report from the CDC details varying incidences of breast cancer among women by demographic characteristics and suggests areas for improvement in treatment and patient education on risk.

What We’re Reading: Moderna Vaccine Efficacy Reduced; Vaccine Mandate Revived; New Combo Against Breast Cancer

December 16th 2021, 2:16pm

Article

Two doses of the Moderna COVID-19 vaccine have reduced efficacy against the Omicron variant; a federal appeals court reinstates the Biden administration’s health care worker vaccine mandate in 26 states; a new combination therapy may reduce breast cancer progression.

Surveys Probe Biosimilars in Oncology

December 13th 2021, 8:32pm

Article

Recent surveys shed light on oncologist and patient perceptions of the switch to biosimilars and patient mental health.

Investigators Estimate Cost of Extending HER2-Directed Therapy With Biosimilars in British Columbia

December 8th 2021, 3:30pm

Article

Costs of extending human epidermal growth factor receptor 2 (HER2) therapy for patients with metastatic breast cancer were estimated in a retrospective study.

Dr Funmi Olopade Previews Her Keynote Address for SABCS

December 6th 2021, 5:45pm

Video

Funmi Olopade, MD, FACP, professor of medicine and human genetics and founding director of the Center for Clinical Cancer Genetics and Global Health at the University of Chicago Medical Center, previews her keynote address for the San Antonio Breast Cancer Symposium (SABCS).

Achieving Equitable Breast Cancer Care: Clinical Trials, Mental Health, and Digital Therapeutics

November 23rd 2021, 2:00pm

Article

Discussions regarding health equity and access to care have long been implicated in breast cancer. Here, key opinion leaders discuss the latest progress in clinical trial access, digital therapeutics, and other efforts that aim to ameliorate these care gaps.

Florida Cancer Specialists & Research Institute Breast Cancer Partnership Receives National Accreditation

October 26th 2021, 6:14pm

Article

Collaboration with community partners recognized for patient care excellence.

Dr Funmi Olopade on WISDOM: When You Ask Women to Participate, They Sign Up

October 20th 2021, 2:00pm

Video

The WISDOM study—Women Informed to Screen Depending On Measures of risk—was launched to test a personalized approach to screening compared to annual mammograms. Funmi Olopade, MD, FACP, is a professor of Medicine and Human Genetics and founding director of the Center for Clinical Cancer Genetics and Global Health at the University of Chicago Medical Center, and a co-investigator of WISDOM. She is an expert on understanding the etiology and genomic basis of cancer progression in diverse populations and has published extensively on both genetic and non-genetic risk factors for breast cancer. She discussed overcoming early challenges of low enrollment of Black women in the study.

What We're Reading: RWE Finds Pfizer, Moderna Vaccines Highly Effective; Signs of COVID-19 Surge; Lawsuit Threatens Free Preventive Care

March 30th 2021, 3:00pm

Article

The Pfizer and Moderna COVID-19 vaccines were shown to be 90% effective in preventing infection in a real-world setting; Biden administration urges states to pause reopening plans amid signs of COVID-19 surge; a lawsuit seeks to end the requirement that preventive services be provided free of charge to Americans.